Milestone Pharmaceuticals Inc. (MIST)
MIST Stock Price Chart
Explore Milestone Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze MIST price movements and trends.
MIST Company Profile
Discover essential business fundamentals and corporate details for Milestone Pharmaceuticals Inc. (MIST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 May 2019
Employees
33.00
Website
https://www.milestonepharma.comCEO
Joseph G. Oliveto
Description
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
MIST Financial Timeline
Browse a chronological timeline of Milestone Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.18, while revenue estimate is $1.10m.
Earnings released on 13 May 2026
EPS came in at -$0.20 falling short of the estimated $0.06 by -433.33%, while revenue for the quarter reached $238.00k , missing expectations by -99.21%.
Earnings released on 20 Mar 2026
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $1.50m , missing expectations by -96.00%.
Earnings released on 12 Nov 2025
EPS came in at -$0.12 surpassing the estimated -$0.17 by +29.41%.
Earnings released on 12 Aug 2025
EPS came in at -$0.20 falling short of the estimated -$0.18 by -11.11%.
Earnings released on 14 May 2025
EPS came in at -$0.31 falling short of the estimated -$0.19 by -63.16%.
Earnings released on 13 Mar 2025
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%.
Earnings released on 12 Nov 2024
EPS came in at -$0.14 surpassing the estimated -$0.16 by +12.50%.
Earnings released on 8 Aug 2024
EPS came in at -$0.14 surpassing the estimated -$0.19 by +26.32%.
Earnings released on 13 May 2024
EPS came in at -$0.21 surpassing the estimated -$0.26 by +19.23%.
Earnings released on 21 Mar 2024
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%, while revenue for the quarter reached -$868.00k .
Earnings released on 13 Nov 2023
EPS came in at -$0.35 surpassing the estimated -$0.38 by +7.89%.
Earnings released on 10 Aug 2023
EPS came in at -$0.37 surpassing the estimated -$0.39 by +5.13%.
Earnings released on 11 May 2023
EPS came in at -$0.35 surpassing the estimated -$0.38 by +7.89%, while revenue for the quarter reached $1.00m .
Earnings released on 29 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.35 by +11.43%, while revenue for the quarter reached $3.50m , beating expectations by +200.00%.
Earnings released on 10 Nov 2022
EPS came in at -$0.34 surpassing the estimated -$0.41 by +17.07%, while revenue for the quarter reached $1.50m .
Earnings released on 10 Aug 2022
EPS came in at -$0.39 falling short of the estimated -$0.36 by -8.33%.
Earnings released on 12 May 2022
EPS came in at -$0.33 surpassing the estimated -$0.39 by +15.38%.
Earnings released on 24 Mar 2022
EPS came in at -$0.40 falling short of the estimated -$0.36 by -11.11%, while revenue for the quarter reached $15.00m .
Earnings released on 12 Nov 2021
EPS came in at -$0.34 surpassing the estimated -$0.38 by +10.53%.
Earnings released on 11 Aug 2021
EPS came in at $0.02 surpassing the estimated -$0.26 by +107.69%, while revenue for the quarter reached $15.00m , beating expectations by +400.00%.
MIST Stock Performance
Access detailed MIST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
